These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 10726965)
1. Haemodynamic responses to a ring-deleted analogue of atrial natriuretic peptide in rats with cirrhosis. Moreau R; Tazi KA; Komeichi H; Pussard E; Lebrec D Liver; 2000 Feb; 20(1):88-92. PubMed ID: 10726965 [TBL] [Abstract][Full Text] [Related]
2. Blunted systemic, splanchnic, and renal hemodynamic responses to atrial natriuretic peptide in rats with cirrhosis. Ohsuga M; Moreau R; Hartleb M; Komeichi H; Lebrec D J Hepatol; 1994 Jan; 20(1):91-6. PubMed ID: 8201228 [TBL] [Abstract][Full Text] [Related]
3. Acute haemodynamic responses and inhibition of tumour necrosis factor-alpha by pentoxifylline in rats with cirrhosis. Soupison T; Yang S; Bernard C; Moreau R; Kirstetter P; D'Almeida M; Cailmail S; Tedgui A; Lebrec D Clin Sci (Lond); 1996 Jul; 91(1):29-33. PubMed ID: 8774257 [TBL] [Abstract][Full Text] [Related]
4. Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites. Gadano A; Moreau R; Vachiery F; Soupison T; Yang S; Cailmail S; Sogni P; Hadengue A; Durand F; Valla D; Lebrec D J Hepatol; 1997 Jun; 26(6):1229-34. PubMed ID: 9210608 [TBL] [Abstract][Full Text] [Related]
5. Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats. Pilette C; Kirstetter P; Sogni P; Cailmail S; Moreau R; Lebrec D J Gastroenterol Hepatol; 1996 Jan; 11(1):1-6. PubMed ID: 8672735 [TBL] [Abstract][Full Text] [Related]
6. Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites. López C; Jiménez W; Arroyo V; La Villa G; Gaya J; Clària J; Rivera F; Rodés J J Hepatol; 1989 Sep; 9(2):217-26. PubMed ID: 2530268 [TBL] [Abstract][Full Text] [Related]
7. Renal effects of atrial natriuretic peptide in cirrhotic rats with and without captopril pretreatment. Brunkhorst R; Wrenger E; Malcharzik C; Brabant G; Koch KM Nephron; 1993; 64(2):275-81. PubMed ID: 8321362 [TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension. Leskinen H; Vuolteenaho O; Toth M; Ruskoaho H Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384 [TBL] [Abstract][Full Text] [Related]
9. Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats. Heller J; Shiozawa T; Trebicka J; Hennenberg M; Schepke M; Neef M; Sauerbruch T Eur J Clin Invest; 2003 Nov; 33(11):1006-12. PubMed ID: 14636305 [TBL] [Abstract][Full Text] [Related]
10. Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis. Komeichi H; Moreau R; Cailmail S; Gaudin C; Lebrec D J Hepatol; 1995 Mar; 22(3):319-25. PubMed ID: 7608483 [TBL] [Abstract][Full Text] [Related]
11. Effects of long-term administration of octreotide on sodium retention and atrial natriuretic peptide in carbon tetrachloride-induced cirrhotic rats. Wang SS; Lee FY; Wu SL; Hwu CM; Chien CH; Lee SD; Tsai YT; Chao Y; Chen CC; Wang PS J Hepatol; 1997 May; 26(5):1128-34. PubMed ID: 9186844 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis. La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200 [TBL] [Abstract][Full Text] [Related]
13. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure. Lee RW; Raya TE; Michael U; Foster S; Meeks T; Goldman S J Pharmacol Exp Ther; 1992 Jan; 260(1):349-54. PubMed ID: 1346164 [TBL] [Abstract][Full Text] [Related]
14. Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats. Park KS; Li Y; Zhang Y; Gerbes AL; Liu H; Swain MG; Lee SS Br J Pharmacol; 2003 May; 139(1):81-8. PubMed ID: 12746226 [TBL] [Abstract][Full Text] [Related]
15. Haemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertension. Pilette C; Moreau R; Sogni P; Kirstetter P; Cailmail S; Pussard E; Lebrec D Eur J Pharmacol; 1996 Sep; 312(1):63-8. PubMed ID: 8891579 [TBL] [Abstract][Full Text] [Related]
16. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction. Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421 [TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide in rats with experimental cirrhosis of the liver without ascites. Olivera A; Gutkowska J; Rodriguez-Puyol D; Fernandez-Cruz A; López-Novoa JM Endocrinology; 1988 Mar; 122(3):840-6. PubMed ID: 2963741 [TBL] [Abstract][Full Text] [Related]
18. Effect of atrial natriuretic peptide on arterial pressure and renal function in cirrhotic rats with ascites. López C; Jiménez W; Arroyo V; Gaya J; Rivera F; Rodés J Rev Esp Fisiol; 1988 Sep; 44(3):265-72. PubMed ID: 2976517 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of a clonidine-induced decrease in portal pressure in normal and cirrhotic conscious rats. Roulot D; Braillon A; Gaudin C; Ozier Y; Girod C; Lebrec D Hepatology; 1989 Oct; 10(4):477-81. PubMed ID: 2777209 [TBL] [Abstract][Full Text] [Related]
20. Impaired natriuretic response to atrial natriuretic peptide in the isolated kidney of rats with experimental cirrhosis. Panos MZ; Gove C; Firth JD; Raine AE; Ledingham JG; Westaby D; Williams R Clin Sci (Lond); 1990 Jul; 79(1):67-71. PubMed ID: 2167793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]